- News
News
Strathclyde researchers to develop preclinical lead drug for advanced prostate and colorectal cancers
Researchers at the University of Strathclyde have been awarded £2.6 million to develop a preclinical lead drug candidate targeted at advanced prostate and colorectal cancers.
More
- News
News
Decade of IBioIC support boosts Scotland’s bioeconomy with £35 million of innovation investment
The Industrial Biotechnology Innovation Centre (IBioIC) has supported the growth of Scotland’s industrial biotechnology sector by helping it to attract £35 million of additional funding for research and development, according to new figures revealed to mark its tenth anniversary.
More
- News
News
University of Glasgow research to eliminate gender bias in AI healthcare
Researchers are setting out to help ensure that the artificial intelligence behind the healthcare monitoring systems of the future is capable of providing the best possible care for both men and women.
More
- News
News
Strathclyde report finds Rapid Cancer Diagnostic Service speeding up treatment
More than one in ten patients seen by new cancer diagnostic services have been referred for cancer treatment, helping to speed up treatment and improve outcomes. Patients waited an average of 14 days from referral, to having cancer ruled in or out.
More
- News
News
Strathclyde’s novel approach to prevent insomnia in breast cancer patients
A novel approach to sleep ‘prehabilitation’ is to be trialled with newly-diagnosed breast cancer patients suffering from early signs of insomnia, in research by the University of Strathclyde and the NHS.
More
- News
News
Digital Health & Care Innovation Centre secures decade-long funding
Technology designed for patients to make informed choices is “the only way” to take Scotland’s medical model into the 21st century, according to the head of an innovation centre hosted at the University of Strathclyde.
More
- News
News
University of Glasgow’s DiRECT Study shows long-term remission of type 2 diabetes with diet intervention
New findings from a three-year observational extension of the landmark Diabetes Remission Clinical Trial DiRECT reveal that, for those in remission from type 2 diabetes at the end of year two of the original study, 26% still remained in remission at year five. The overall remission rate was 13% of…
More
- News
News
University of Glasgow develops terahetz wave biosensor for early skin cancer detection
Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses.
More